{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T21:53:59Z","timestamp":1774043639952,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1014040","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000}}],"reference-count":87,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010446","name":"Institute for Basic Science","doi-asserted-by":"publisher","award":["IBS-R029-C3"],"award-info":[{"award-number":["IBS-R029-C3"]}],"id":[{"id":"10.13039\/501100010446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2025-25397599"],"award-info":[{"award-number":["RS-2025-25397599"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Mathematical Sciences","award":["NIMS-B25810000"],"award-info":[{"award-number":["NIMS-B25810000"]}]},{"name":"National Institute for Mathematical Sciences","award":["NIMS-B25810000"],"award-info":[{"award-number":["NIMS-B25810000"]}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Contraception is essential for reproductive health and women\u2019s empowerment because it allows informed choices about pregnancy prevention. Oral contraceptives (OCs) are a popular method due to their accessibility and high level of effectiveness in attaining contraception through the suppression of ovulation. However, current OC regimens do not consider circadian hormonal rhythms, which significantly influence hormone secretion and drug metabolism. Accounting for circadian rhythms may further reduce the dosage of current formulations, which pose risks, including an increased likelihood of venous thromboembolism. We addressed this gap by developing a mathematical model that integrates circadian rhythms with contraceptive pharmacokinetics. Our results show that daytime OC dosing reduces the required ethinyl estradiol (EE) dose by about 6% and the required dienogest (DNG) dose by about 52% compared to evening dosing, due to the alignment of EE and DNG concentrations with luteinizing hormone production peaks. We further lowered the EE dose by about 67% using an optimal nonconstant regimen and decreased the number of intake days from 21 to 8. This dual-timescale optimization demonstrates how incorporating circadian rhythms can significantly enhance contraceptive regimens, enabling safer and more effective dosing strategies with broader implications for chronopharmacological interventions.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1014040","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:52:20Z","timestamp":1773424340000},"page":"e1014040","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing oral contraceptive timing: Daytime intake reduces doses and enhances efficacy"],"prefix":"10.1371","volume":"22","author":[{"given":"Brenda Lyn","family":"Gavina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeyong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olive","family":"Cawiding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunhwa","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungwook","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7842-2172","authenticated-orcid":true,"given":"Jae Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"3","key":"pcbi.1014040.ref001","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmi005","article-title":"Combined oral contraceptives in the treatment of polycystic ovary syndrome","volume":"11","author":"J Vrb\u00edkov\u00e1","year":"2005","journal-title":"Hum Reprod Update"},{"issue":"1","key":"pcbi.1014040.ref002","doi-asserted-by":"crossref","DOI":"10.1093\/ejendo\/lvad082","article-title":"Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"189","author":"M Forslund","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"pcbi.1014040.ref003","doi-asserted-by":"crossref","unstructured":"Schindler AE. Hormonal contraceptives and endometriosis\/adenomyosis. 2010.","DOI":"10.3109\/09513590.2010.534612"},{"issue":"2","key":"pcbi.1014040.ref004","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s42000-025-00636-4","article-title":"The effect of combined oral contraceptive pills on angiogenesis in endometriotic lesions","volume":"24","author":"A Siampalis","year":"2025","journal-title":"Hormones (Athens)"},{"key":"pcbi.1014040.ref005","volume-title":"Clinical gynecologic endocrinology and infertility","author":"L Speroff","year":"2011","edition":"8"},{"issue":"1","key":"pcbi.1014040.ref006","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0015-0282(01)01824-6","article-title":"Ovarian function during and after treatment with the new progestagen Org 30659","volume":"76","author":"A Obruca","year":"2001","journal-title":"Fertil Steril"},{"key":"pcbi.1014040.ref007","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9378(99)70120-1","article-title":"The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices","volume":"181","author":"R Rivera","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"pcbi.1014040.ref008","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1586\/eog.11.48","article-title":"Currently available combined oral contraception","volume":"6","author":"T Kimble","year":"2011","journal-title":"Expert Review of Obstetrics & Gynecology"},{"issue":"1","key":"pcbi.1014040.ref009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beem.2012.11.004","article-title":"History of oral contraceptive drugs and their use worldwide","volume":"27","author":"S Christin-Maitre","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"pcbi.1014040.ref010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-7824(95)00074-K","article-title":"Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation","volume":"51","author":"MJ Rosenberg","year":"1995","journal-title":"Contraception"},{"issue":"1","key":"pcbi.1014040.ref011","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.contraception.2009.07.011","article-title":"Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use","volume":"81","author":"I Wiegratz","year":"2010","journal-title":"Contraception"},{"key":"pcbi.1014040.ref012","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"\u00d8 Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"pcbi.1014040.ref013","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.thromres.2018.03.005","article-title":"Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: the role of the progestogen type and estrogen dose","volume":"165","author":"C Oedingen","year":"2018","journal-title":"Thromb Res"},{"key":"pcbi.1014040.ref014","doi-asserted-by":"crossref","unstructured":"Johansson T. Arterial thrombosis in users of contemporary hormonal contraception. 2025.","DOI":"10.1136\/bmj.r237"},{"issue":"1","key":"pcbi.1014040.ref015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0010-7824(72)80003-9","article-title":"A report of a collaborative dose-response clinical study using decreasing doses of combination oral contraceptives","volume":"6","author":"SN Preston","year":"1972","journal-title":"Contraception"},{"issue":"1","key":"pcbi.1014040.ref016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01986523","article-title":"Low dose contraceptive formulations: is further reduction in steroid dosage justified?","volume":"10","author":"M Elstein","year":"1994","journal-title":"Adv Contracept"},{"issue":"3","key":"pcbi.1014040.ref017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0010-7824(01)00316-X","article-title":"An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables","volume":"65","author":"J Endrikat","year":"2002","journal-title":"Contraception"},{"issue":"4","key":"pcbi.1014040.ref018","article-title":"Toward an optimal contraception dosing strategy","volume":"19","author":"BLA Gavina","year":"2023","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"pcbi.1014040.ref019","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0010-7824(83)90086-0","article-title":"Pharmacokinetics of oral contraceptive steroids after morning or evening administration","volume":"27","author":"O Kiriwat","year":"1983","journal-title":"Contraception"},{"issue":"12","key":"pcbi.1014040.ref020","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1210\/jc.2019-00803","article-title":"Endogenous circadian regulation of female reproductive hormones","volume":"104","author":"SA Rahman","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"pcbi.1014040.ref021","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/cpt.2073","article-title":"Circadian variation in efficacy of medications","volume":"109","author":"JC Walton","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"6453","key":"pcbi.1014040.ref022","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.aax7621","article-title":"Dosing time matters","volume":"365","author":"MD Ruben","year":"2019","journal-title":"Science"},{"issue":"6","key":"pcbi.1014040.ref023","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/07487304211044301","article-title":"Circadian rhythms, disease and chronotherapy","volume":"36","author":"Y Lee","year":"2021","journal-title":"J Biol Rhythms"},{"issue":"7","key":"pcbi.1014040.ref024","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3390\/pharmaceutics14071424","article-title":"An overview of the Circadian clock in the frame of chronotherapy: from bench to bedside","volume":"14","author":"A Vandenberghe","year":"2022","journal-title":"Pharmaceutics"},{"key":"pcbi.1014040.ref025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coisb.2020.07.007","article-title":"Wearable technology and systems modeling for personalized chronotherapy","volume":"21","author":"DW Kim","year":"2020","journal-title":"Current Opinion in Systems Biology"},{"issue":"7","key":"pcbi.1014040.ref026","article-title":"Modeling and validating chronic pharmacological manipulation of circadian rhythms","volume":"2","author":"JK Kim","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"7","key":"pcbi.1014040.ref027","article-title":"Systems approach reveals photosensitivity and PER2 level as determinants of clock-modulator efficacy","volume":"15","author":"DW Kim","year":"2019","journal-title":"Mol Syst Biol"},{"issue":"3","key":"pcbi.1014040.ref028","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s11096-013-9749-0","article-title":"Timing is important in medication administration: a timely review of chronotherapy research","volume":"35","author":"G Kaur","year":"2013","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"pcbi.1014040.ref029","article-title":"Chemotherapy delivery time affects treatment outcomes of female patients with diffuse large B cell lymphoma","volume":"8","author":"DW Kim","year":"2023","journal-title":"JCI Insight"},{"issue":"4695","key":"pcbi.1014040.ref030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1126\/science.3883493","article-title":"Circadian timing of cancer chemotherapy","volume":"228","author":"WJ Hrushesky","year":"1985","journal-title":"Science"},{"issue":"4","key":"pcbi.1014040.ref031","first-page":"611","article-title":"Chronotherapeutics: the relevance of timing in cancer therapy","volume":"17","author":"F L\u00e9vi","year":"2006","journal-title":"Cancer Causes Control"},{"issue":"9079","key":"pcbi.1014040.ref032","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(97)03358-8","article-title":"Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy","volume":"350","author":"F L\u00e9vi","year":"1997","journal-title":"Lancet"},{"issue":"5","key":"pcbi.1014040.ref033","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1470-2045(00)00326-0","article-title":"Circadian chronotherapy for human cancers","volume":"2","author":"F L\u00e9vi","year":"2001","journal-title":"Lancet Oncol"},{"key":"pcbi.1014040.ref034","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.addr.2010.06.002","article-title":"Chronotherapy and the molecular clock: Clinical implications in oncology","volume":"62","author":"PF Innominato","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"pcbi.1014040.ref035","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(21)00639-2","article-title":"Toxicity and efficacy of chronomodulated chemotherapy: a systematic review","volume":"23","author":"MI Printezi","year":"2022","journal-title":"Lancet Oncol"},{"key":"pcbi.1014040.ref036","doi-asserted-by":"crossref","unstructured":"Levi F, Ballesta A, Karabou\u00e9 A, Huang Q, Focan C, Chollet P. Optimizing FOLFIRINOX tolerability in patients with colorectal cancer through dosing irinotecan in the morning for men and in the afternoon for women. 2020.","DOI":"10.1200\/JCO.2020.38.4_suppl.120"},{"key":"pcbi.1014040.ref037","doi-asserted-by":"crossref","first-page":"105607","DOI":"10.1016\/j.ebiom.2025.105607","article-title":"Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental study","volume":"113","author":"Z Huang","year":"2025","journal-title":"EBioMedicine"},{"issue":"11","key":"pcbi.1014040.ref038","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11906-018-0897-4","article-title":"Chronotherapy for hypertension","volume":"20","author":"NP Bowles","year":"2018","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"pcbi.1014040.ref039","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/07420528.2011.553017","article-title":"Methotrexate chronotherapy is effective against rheumatoid arthritis","volume":"28","author":"H To","year":"2011","journal-title":"Chronobiol Int"},{"key":"pcbi.1014040.ref040","unstructured":"Swedish Medical Products Agency. Public assessment report: Dienogest\/ethinylestradiol Exeltis (2 mg\/0.02 mg, prolonged-release tablet). 2024."},{"key":"pcbi.1014040.ref041","doi-asserted-by":"crossref","DOI":"10.4324\/9780203756508","volume-title":"European drug index: European drug registrations","author":"NF Muller","year":"2022"},{"issue":"1","key":"pcbi.1014040.ref042","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/endocrines6010012","article-title":"Comparative study of 0.5 mg dienogest tablets (1 mg\/Day) and continuous low-dose estrogen\/progestin for dysmenorrhea: a retrospective analysis\u2014influence of bleeding-related factors such as endometrial polyps, uterine fibroids, and adenomyosis","volume":"6","author":"H Yokosuka","year":"2025","journal-title":"Endocrines"},{"issue":"6","key":"pcbi.1014040.ref043","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/11536320-000000000-00000","article-title":"Ethinylestradiol\/dienogest in oral contraception","volume":"70","author":"EF P\u00e9rez-Campos","year":"2010","journal-title":"Drugs"},{"issue":"5","key":"pcbi.1014040.ref044","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/09513590.2012.662547","article-title":"An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate\/dienogest","volume":"28","author":"F Fruzzetti","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"pcbi.1014040.ref045","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1552-6909.2006.00051.x","article-title":"Variability in the phases of the menstrual cycle","volume":"35","author":"RJ Fehring","year":"2006","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"1","key":"pcbi.1014040.ref046","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11538-013-9913-7","article-title":"Modeling endocrine control of the pituitary-ovarian axis: androgenic influence and chaotic dynamics","volume":"76","author":"AO Hendrix","year":"2014","journal-title":"Bull Math Biol"},{"key":"pcbi.1014040.ref047","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41746-019-0152-7","article-title":"Real-world menstrual cycle characteristics of more than 600,000 menstrual cycles","volume":"2","author":"JR Bull","year":"2019","journal-title":"NPJ Digit Med"},{"issue":"3","key":"pcbi.1014040.ref048","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0010-7824(97)00123-6","article-title":"Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest","volume":"56","author":"J Spona","year":"1997","journal-title":"Contraception"},{"issue":"9472","key":"pcbi.1014040.ref049","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(05)66527-0","article-title":"Missed contraceptive pills and the critical pill-free interval","volume":"365","author":"D Mansour","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"pcbi.1014040.ref050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/13625187.2017.1295437","article-title":"Missed pills: frequency, reasons, consequences and solutions","volume":"22","author":"N Chabbert-Buffet","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"2","key":"pcbi.1014040.ref051","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.contraception.2005.08.003","article-title":"Effective use of hormonal contraceptives: Part I: Combined oral contraceptive pills","volume":"73","author":"KM Curtis","year":"2006","journal-title":"Contraception"},{"issue":"3","key":"pcbi.1014040.ref052","first-page":"386","article-title":"Occurrence and function of corpora lutea during different forms of oral contraception","volume":"57","author":"E \u00d8stergaard","year":"1968","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"5703","key":"pcbi.1014040.ref053","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmj.2.5703.203","article-title":"Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs","volume":"2","author":"WH Inman","year":"1970","journal-title":"Br Med J"},{"issue":"3","key":"pcbi.1014040.ref054","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1783\/147118909788707878","article-title":"Qlaira: a \u201cnatural\u201d change of direction","volume":"35","author":"D Mansour","year":"2009","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"12","key":"pcbi.1014040.ref055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1012398","article-title":"Comment on: toward an optimal contraception dosing strategy","volume":"20","author":"G Benagiano","year":"2024","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"pcbi.1014040.ref056","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007848","article-title":"Mechanistic model of hormonal contraception","volume":"16","author":"AA Wright","year":"2020","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"pcbi.1014040.ref057","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jtbi.2007.03.011","article-title":"A complex mathematical model of the human menstrual cycle","volume":"247","author":"I Reinecke","year":"2007","journal-title":"J Theor Biol"},{"key":"pcbi.1014040.ref058","volume-title":"The normal menstrual cycle and the control of ovulation","author":"BG Reed","year":"2000"},{"key":"pcbi.1014040.ref059","volume-title":"Mathematical modeling and simulation of the female menstrual cycle","author":"I Reinecke","year":"2009"},{"issue":"4","key":"pcbi.1014040.ref060","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.fertnstert.2009.06.057","article-title":"Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24\/4-day intake regimen over three cycles","volume":"94","author":"J Spona","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"pcbi.1014040.ref061","first-page":"33","article-title":"Comparison of various therapies for the luteinized unruptured follicle syndrome","volume":"37","author":"JH Check","year":"1992","journal-title":"Int J Fertil"},{"key":"pcbi.1014040.ref062","unstructured":"Bormann I. Digitizeit. 2021. https:\/\/www.digitizeit.xyz\/"},{"issue":"2","key":"pcbi.1014040.ref063","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.celrep.2014.09.021","article-title":"Rhythmic degradation explains and unifies circadian transcriptome and proteome data","volume":"9","author":"S L\u00fcck","year":"2014","journal-title":"Cell Rep"},{"key":"pcbi.1014040.ref064","volume-title":"Differential equation models for the hormonal regulation of the menstrual cycle","author":"L Harris","year":"2002"},{"key":"pcbi.1014040.ref065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mbs.2014.08.011","article-title":"Modeling endocrine regulation of the menstrual cycle using delay differential equations","volume":"257","author":"LA Harris","year":"2014","journal-title":"Math Biosci"},{"key":"pcbi.1014040.ref066","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jtbi.2017.01.007","article-title":"A model of ovulatory regulation examining the effects of insulin-mediated testosterone production on ovulatory function","volume":"416","author":"EJ Graham","year":"2017","journal-title":"J Theor Biol"},{"key":"pcbi.1014040.ref067","doi-asserted-by":"crossref","first-page":"108979","DOI":"10.1016\/j.mbs.2023.108979","article-title":"Reduced model for female endocrine dynamics: validation and functional variations","volume":"358","author":"EJ Graham","year":"2023","journal-title":"Math Biosci"},{"key":"pcbi.1014040.ref068","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jtbi.2012.11.020","article-title":"A mathematical model of the human menstrual cycle for the administration of GnRH analogues","volume":"321","author":"S R\u00f6blitz","year":"2013","journal-title":"J Theor Biol"},{"key":"pcbi.1014040.ref069","doi-asserted-by":"crossref","unstructured":"Zhao L, Kim R, Oremland LS, Chowkwale M, Pillis LGd, Brooks HZ. A survey of mathematical modeling of hormonal contraception and the menstrual cycle. Mathematical modeling for women's health: collaborative workshop for women in mathematical biology. 2024. p. 51\u201382.","DOI":"10.1007\/978-3-031-58516-6_3"},{"issue":"2","key":"pcbi.1014040.ref070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mbs.2011.09.001","article-title":"Dynamics and bifurcation of a model for hormonal control of the menstrual cycle with inhibin delay","volume":"234","author":"A Margolskee","year":"2011","journal-title":"Math Biosci"},{"issue":"4","key":"pcbi.1014040.ref071","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/07487304241247893","article-title":"Using wearable skin temperature data to advance tracking and characterization of the menstrual cycle in a real-world setting","volume":"39","author":"M Gombert-Labedens","year":"2024","journal-title":"J Biol Rhythms"},{"issue":"2","key":"pcbi.1014040.ref072","article-title":"Circadian regulation of sinoatrial nodal cell pacemaking function: Dissecting the roles of autonomic control, body temperature, and local circadian rhythmicity","volume":"20","author":"P Li","year":"2024","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"pcbi.1014040.ref073","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/0748730412469499","article-title":"Modeling the effects of the circadian clock on cardiac electrophysiology","volume":"28","author":"P Fotiadis","year":"2013","journal-title":"J Biol Rhythms"},{"issue":"1","key":"pcbi.1014040.ref074","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1038\/s41598-020-73669-x","article-title":"Modeling circadian regulation of ovulation timing: age-related disruption of estrous cyclicity","volume":"10","author":"T Ohara","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"pcbi.1014040.ref075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1208\/s12248-015-9841-6","article-title":"Modeling testosterone circadian rhythm in hypogonadal males: effect of age and circannual variations","volume":"18","author":"M Gonz\u00e1lez-Sales","year":"2016","journal-title":"AAPS J"},{"key":"pcbi.1014040.ref076","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yjmcc.2025.08.012","article-title":"Circadian determinants of heart rhythm and arrhythmias","volume":"208","author":"M Boyett","year":"2025","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"pcbi.1014040.ref077","article-title":"Cardiogenic and chronobiological mechanisms in seizure-induced sinus arrhythmias","volume":"21","author":"P Li","year":"2025","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"pcbi.1014040.ref078","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/en.2018-00889","article-title":"GnRH-a key regulator of FSH","volume":"160","author":"GA Stamatiades","year":"2019","journal-title":"Endocrinology"},{"issue":"5","key":"pcbi.1014040.ref079","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.xphs.2020.01.025","article-title":"A new method for the estimation of absorption rate constant in two-compartment model by extravascular administration","volume":"109","author":"Y Zeng","year":"2020","journal-title":"J Pharm Sci"},{"key":"pcbi.1014040.ref080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/13625189909085261","article-title":"Clinical profile of valette","volume":"4","author":"J Spona","year":"1999","journal-title":"The European Journal of Contraception & Reproductive Health Care"},{"issue":"1","key":"pcbi.1014040.ref081","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1137\/S1052623496303470","article-title":"Convergence properties of the Nelder--Mead simplex method in low dimensions","volume":"9","author":"JC Lagarias","year":"1998","journal-title":"SIAM J Optim"},{"key":"pcbi.1014040.ref082","volume-title":"An introduction to optimization","author":"EK Chong","year":"2013","edition":"4"},{"issue":"78","key":"pcbi.1014040.ref083","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.21105\/joss.04723","article-title":"Metaheuristics: a Julia package for single- and multi-objective optimization","volume":"7","author":"J-A Mej\u00eda-de-Dios","year":"2022","journal-title":"JOSS"},{"issue":"2","key":"pcbi.1014040.ref084","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1109\/4235.996017","article-title":"A fast and elitist multiobjective genetic algorithm: NSGA-II","volume":"6","author":"K Deb","year":"2002","journal-title":"IEEE Trans Evol Computat"},{"issue":"1","key":"pcbi.1014040.ref085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1109\/TEVC.2020.3004012","article-title":"A coevolutionary framework for constrained multiobjective optimization problems","volume":"25","author":"Y Tian","year":"2021","journal-title":"IEEE Trans Evol Computat"},{"key":"pcbi.1014040.ref086","doi-asserted-by":"crossref","DOI":"10.1002\/9780470386361","volume-title":"Formulation and analytical development for low-dose oral drug products","author":"J Zheng","year":"2009"},{"key":"pcbi.1014040.ref087","unstructured":"Greaves FC, Swarbrick J, Beasley MW, Suddith AW, Caldwell HC. Method for preparing low dose pharmaceutical products. 1999."}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1014040","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:02:50Z","timestamp":1774036970000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014040"}},"subtitle":[],"editor":[{"given":"Marc R.","family":"Birtwistle","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":87,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1014040","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]}}}